Exact Mass: 494.1822
Exact Mass Matches: 494.1822
Found 223 metabolites which its exact mass value is equals to given mass value 494.1822
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Harpagoside
Harpagoside is a terpene glycoside. Harpagoside is a natural product found in Verbascum lychnitis, Verbascum sinuatum, and other organisms with data available. See also: Harpagophytum procumbens root (part of); Harpagophytum zeyheri root (part of). Origin: Plant; SubCategory_DNP: Monoterpenoids, Iridoid monoterpenoids Harpagoside is isolated from Harpagophytum procumbens. Harpagoside has inhibitory effects on COX-1 and COX-2 activity and inhibits NO production[1]. Harpagoside is isolated from Harpagophytum procumbens. Harpagoside has inhibitory effects on COX-1 and COX-2 activity and inhibits NO production[1].
Amdro
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4856; ORIGINAL_PRECURSOR_SCAN_NO 4854 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4845; ORIGINAL_PRECURSOR_SCAN_NO 4843 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4858; ORIGINAL_PRECURSOR_SCAN_NO 4856 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4880; ORIGINAL_PRECURSOR_SCAN_NO 4878 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9324; ORIGINAL_PRECURSOR_SCAN_NO 9322 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9337; ORIGINAL_PRECURSOR_SCAN_NO 9336 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9290; ORIGINAL_PRECURSOR_SCAN_NO 9289 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4940; ORIGINAL_PRECURSOR_SCAN_NO 4938 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4851; ORIGINAL_PRECURSOR_SCAN_NO 4847 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9266; ORIGINAL_PRECURSOR_SCAN_NO 9265 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9299; ORIGINAL_PRECURSOR_SCAN_NO 9298 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9304; ORIGINAL_PRECURSOR_SCAN_NO 9303
3,6,9,12-Tetraazatetradecanedioic acid, 3,6,9,12-tetrakis(carboxymethyl)-
D064449 - Sequestering Agents > D002614 - Chelating Agents
2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Harpagoside
combretastatin A-1 2-beta-D-glucoside|combretastatin A-1 2-O-beta-D-glucopyranoside
3beta-hydroxystilpnotomentolide-8-O-(5-acetoxysenecioate)
4-[4-(Tetra-O-acetyl-beta-D-glucopyranosyloxy)-phenyl]-butan-2-on|4-[4-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-phenyl]-butan-2-one|raspberry ketone tetra-O-acetyl-beta-D-glucopyranoside
(5S)-1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxyheptane-3-on-5-O-beta-D-xylopyranoside|oregonin
8alpha-(5-acetoxy senecioyloxy)-3-beta-hydroxy-10alphaH-hirsutinolide-13-O-acetate|8alpha-<5-acetoxy senecioyloxy>-3-beta-hydroxy-10alphaH-hirsutinolide-13-O-acetate
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine
[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate
[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate_minor
[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate_major
hydramethylnon
Cys Cys Asn Arg
Cys Cys Arg Asn
Cys Glu Phe Pro
Cys Glu Ile Met
Cys Glu Leu Met
Cys Glu Met Ile
Cys Glu Met Leu
Cys Glu Pro Phe
Cys Phe Glu Pro
Cys Phe Pro Glu
Cys Ile Glu Met
Cys Ile Met Glu
Cys Leu Glu Met
Cys Leu Met Glu
Cys Met Glu Ile
Cys Met Glu Leu
Cys Met Ile Glu
Cys Met Leu Glu
Cys Asn Cys Arg
Cys Asn Arg Cys
Cys Pro Glu Phe
Cys Pro Phe Glu
Cys Arg Cys Asn
Cys Arg Asn Cys
Asp His His Ser
Asp His Ser His
Asp Met Met Val
Asp Met Val Met
Asp Ser His His
Asp Val Met Met
Glu Cys Phe Pro
Glu Cys Ile Met
Glu Cys Leu Met
Glu Cys Met Ile
Glu Cys Met Leu
Glu Cys Pro Phe
Glu Phe Cys Pro
Glu Phe Pro Cys
Glu Ile Cys Met
Glu Ile Met Cys
Glu Leu Cys Met
Glu Leu Met Cys
Glu Met Cys Ile
Glu Met Cys Leu
Glu Met Ile Cys
Glu Met Leu Cys
Glu Pro Cys Phe
Glu Pro Phe Cys
Phe Cys Glu Pro
Phe Cys Pro Glu
Phe Glu Cys Pro
Phe Glu Pro Cys
Phe Pro Cys Glu
Phe Pro Glu Cys
His Asp His Ser
His Asp Ser His
His His Asp Ser
His His Ser Asp
His Ser Asp His
His Ser His Asp
Ile Cys Glu Met
Ile Cys Met Glu
Ile Glu Cys Met
Ile Glu Met Cys
Ile Met Cys Glu
Ile Met Glu Cys
Leu Cys Glu Met
Leu Cys Met Glu
Leu Glu Cys Met
Leu Glu Met Cys
Leu Met Cys Glu
Leu Met Glu Cys
Met Cys Glu Ile
Met Cys Glu Leu
Met Cys Ile Glu
Met Cys Leu Glu
Met Asp Met Val
Met Asp Val Met
Met Glu Cys Ile
Met Glu Cys Leu
Met Glu Ile Cys
Met Glu Leu Cys
Met Ile Cys Glu
Met Ile Glu Cys
Met Leu Cys Glu
Met Leu Glu Cys
Met Met Asp Val
Met Met Val Asp
Met Val Asp Met
Met Val Met Asp
Asn Cys Cys Arg
Asn Cys Arg Cys
Asn Arg Cys Cys
Pro Cys Glu Phe
Pro Cys Phe Glu
Pro Glu Cys Phe
Pro Glu Phe Cys
Pro Phe Cys Glu
Pro Phe Glu Cys
Arg Cys Cys Asn
Arg Cys Asn Cys
Arg Asn Cys Cys
Ser Asp His His
Ser His Asp His
Ser His His Asp
Val Asp Met Met
Val Met Asp Met
Val Met Met Asp
4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzyl 2,3-dihydroxy-2-(4-hydroxybenzyl)butanoate
WZ4002
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
(4R,5S)-2-(4-(TERT-BUTYL)-2-ETHOXYPHENYL)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIMETHYL-4,5-DIHYDRO-1H-IMIDAZOLE
Toceranib phosphate
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Arformoterol tartrate
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
4-[3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoic acid
15-O-propionylbruceolide
A quassinoid that is the 15-O-propionyl derivative of bruceolide. It has been isolated from Brucea javanica and Brucea sumatrana.
N-[4-[cyano-[3-[2-(4-morpholinyl)ethylamino]-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide
2-[(3S,6aS,8R,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
N-[[(4R,5S)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4R,5S)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4S,5R)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4R,5R)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
2-[(3S,6aR,8R,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
2-[(3R,6aS,8R,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
N-[[(4S,5R)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4S,5S)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4S,5S)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(4R,5R)-8-(2-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
2-[(3R,6aR,8S,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
2-[(3R,6aS,8S,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
2-[(3S,6aR,8S,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
2-[(3R,6aR,8R,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
3,4,5-trihydroxy-6-[(14-hydroxy-3-methyl-1,7-dioxo-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-16-yl)oxy]oxane-2-carboxylic acid
[(4aS,5R,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
3-hydroxy-2-{[(1e)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-[(2-oxo-2-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}ethyl)amino]cyclohex-2-en-1-ylidene]amino}propanoic acid
12-[(acetyloxy)methyl]-5-hydroxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 4-(acetyloxy)-3-methylbut-2-enoate
4-O-methylpaeoniflorin
{"Ingredient_id": "HBIN010793","Ingredient_name": "4-O-methylpaeoniflorin","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)OC","Ingredient_weight": "494.5 g/mol","OB_score": "25.70632536","CAS_id": "NA","SymMap_id": "SMIT08816","TCMID_id": "33122","TCMSP_id": "MOL007368","TCM_ID_id": "NA","PubChem_id": "46882921","DrugBank_id": "NA"}
4-o-methyl-paeoniflorin
{"Ingredient_id": "HBIN010794","Ingredient_name": "4-o-methyl-paeoniflorin","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)OC","Ingredient_weight": "494.5 g/mol","OB_score": "25.70632536","CAS_id": "NA","SymMap_id": "SMIT08529","TCMID_id": "NA","TCMSP_id": "MOL007011","TCM_ID_id": "NA","PubChem_id": "46882921","DrugBank_id": "NA"}
ajugol; 6-o-(4-hydroxy-e-cinnamoyl)
{"Ingredient_id": "HBIN014996","Ingredient_name": "ajugol; 6-o-(4-hydroxy-e-cinnamoyl)","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "NA","Ingredient_weight": "494.49","OB_score": "NA","CAS_id": "124168-05-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7087","PubChem_id": "NA","DrugBank_id": "NA"}